Literature DB >> 19959545

Femininity and sarcolemmal KATP channels: a matter of the heart and the heart of the matter.

Aleksandar Jovanović1.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19959545      PMCID: PMC2805356          DOI: 10.1113/jphysiol.2009.183004

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  5 in total

1.  ATP-sensitive potassium channel traffic regulation by adenosine and protein kinase C.

Authors:  Keli Hu; Cindy Shen Huang; Yuh Nung Jan; Lily Yeh Jan
Journal:  Neuron       Date:  2003-05-08       Impact factor: 17.173

Review 2.  SURA2 targeting for cardioprotection?

Authors:  Aleksandar Jovanović; Sofija Jovanović
Journal:  Curr Opin Pharmacol       Date:  2008-12-10       Impact factor: 5.547

3.  PKC-permitted elevation of sarcolemmal KATP concentration may explain female-specific resistance to myocardial infarction.

Authors:  Andrew G Edwards; Meredith L Rees; Rachel A Gioscia; Derek K Zachman; Joshua M Lynch; Jason C Browder; Adam J Chicco; Russell L Moore
Journal:  J Physiol       Date:  2009-10-05       Impact factor: 5.182

4.  17Beta-estradiol regulates expression of K(ATP) channels in heart-derived H9c2 cells.

Authors:  Harri J Ranki; Grant R Budas; Russell M Crawford; Anthony M Davies; Aleksandar Jovanović
Journal:  J Am Coll Cardiol       Date:  2002-07-17       Impact factor: 24.094

5.  AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K(+) channels.

Authors:  Andrey Sukhodub; Sofija Jovanović; Qingyou Du; Grant Budas; Allyson K Clelland; Mei Shen; Kei Sakamoto; Rong Tian; Aleksandar Jovanović
Journal:  J Cell Physiol       Date:  2007-01       Impact factor: 6.384

  5 in total
  1 in total

1.  Molecular mechanisms in exercise-induced cardioprotection.

Authors:  Saeid Golbidi; Ismail Laher
Journal:  Cardiol Res Pract       Date:  2011-03-06       Impact factor: 1.866

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.